What: An analysis of prescription stimulant use with over 80,000 patients found the highest increase among women ages 35 to 64, going from 1.2 million in the first quarter of 2019 to 1.7 million in the last quarter of 2022. Despite that increase, reported prescription misuse was also lowest for that group.
Key line: “Findings may suggest potential progress in addressing the mental health care gap for middle-aged women and the need for evidence-based clinical guidance and training on benefits and risks of prescription stimulants for adults.”
Source: JAMA Psychiatry